verapamil has been researched along with Angiospasm, Intracranial in 45 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-dose IA verapamil treatment is well-tolerated in the high-risk aneurysmal subarachnoid hemorrhage population that experience severe, symptomatic CVS with good functional outcomes at follow-up." | 8.02 | The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. ( Esplin, N; Gigliotti, MJ; Mao, G; Sexton, K, 2021) |
| "We studied 11 patients with poor-grade aneurysmal subarachnoid hemorrhages who underwent multimodality brain monitoring and angiography with infusion of high-dose intra-arterial verapamil (≥15 mg total dose)." | 7.77 | High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. ( Badjatia, N; Claassen, J; Connolly, ES; Fernandez, L; Helbok, R; Kurtz, P; Lavine, S; Lee, K; Mayer, SA; Meyers, P; Schmidt, M; Stuart, RM, 2011) |
| " Intra-arterial verapamil was started; during this treatment, the patient developed right-sided focal motor seizures." | 7.74 | Intra-arterial verapamil-induced seizures: case report and review of the literature. ( Nwagwu, CI; Westhout, FD, 2007) |
| "The only pharmacologic prophylaxis for cerebral vasospasm after subarachnoid hemorrhage is oral nimodipine." | 5.46 | Verapamil eluting stents as a possible treatment for vasospasm after subarachnoid hemorrhage. ( Bhambri, P; Mitha, AP; Sarvi, A; Sundararaj, U; Wong, JH, 2017) |
| "According to angiorraphy cerebral vasospasm in acute rupture of an aneurysm is detected in 50-70% of cases, and the risk of ischemia on it's background is 19-46%." | 5.39 | [Intra-arterial injection of verapamil in treatment of cerebral vasospasm in a patient with acute subarachnoid hemorrhage from an aneurysm: case report]. ( Éliava, ShSh; Iakovlev, SB; Lubnin, AIu; Mikeladze, KG; Shekhtman, OD; Tabasaranskiĭ, TF, 2013) |
| "The first results of intracisternal administration of verapamil for the prevention and treatment of cerebral vasospasm (CVS) in patients in the acute period of subarachnoid hemorrhage (SAH) after microsurgical clipping of cerebral aneurysms are presented." | 5.30 | [Intracisternal administration of verapamil for the prevention and treatment of vasospasm in patients after microsurgical treatment of cerebral aneurysms in the acute period of hemorrhage]. ( Baranich, AI; Belousova, OB; Eliava, SS; Gorozhanin, VA; Kheyreddin, AS; Konovalov, AN; Kurdyumova, NV; Mikeladze, KG; Okishev, DN; Pilipenko, YV; Savin, IA; Shekhtman, OD; Spiru, AM; Tabasaransky, TF; Varyukhina, MD; Vinogradov, EV, 2019) |
| "High-dose IA verapamil treatment is well-tolerated in the high-risk aneurysmal subarachnoid hemorrhage population that experience severe, symptomatic CVS with good functional outcomes at follow-up." | 4.02 | The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. ( Esplin, N; Gigliotti, MJ; Mao, G; Sexton, K, 2021) |
| "We outline the clinical presentation of a 56-year-old female with spontaneous subarachnoid hemorrhage with intraventricular extension in a coma from a petroclival meningioma taking escitalopram for depression and high-dose estrogen replacement therapy for menopause." | 3.96 | Intracranial Hemorrhage from Meningioma: 2 Novel Risk Factors. ( Patel, NJ; Penn, D; Pressman, E, 2020) |
| "Using PubMed and Google Scholar, we performed a search of the English language literature with several combinations of the keywords "intra-arterial", "calcium channel blockers", "reversible cerebral vasoconstriction syndrome", "RCVS", "nimodipine", "verapamil", "milrinone", and "nicardipine" to identify studies in which RCVS was treated with IA calcium channel blockers." | 3.88 | Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome ( Al-Mufti, F; Alchaki, A; Dodson, V; El-Ghanem, M; Gupta, G; Hidalgo, A; Nuoman, R; Roychowdhury, S; Sutherland, A; Thabet, A; Wajswol, E, 2018) |
| "We studied 11 patients with poor-grade aneurysmal subarachnoid hemorrhages who underwent multimodality brain monitoring and angiography with infusion of high-dose intra-arterial verapamil (≥15 mg total dose)." | 3.77 | High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. ( Badjatia, N; Claassen, J; Connolly, ES; Fernandez, L; Helbok, R; Kurtz, P; Lavine, S; Lee, K; Mayer, SA; Meyers, P; Schmidt, M; Stuart, RM, 2011) |
| " Data were retrospectively collected, including age, sex, Hunt and Hess grade, Fisher grade, aneurysm location, aneurysm treatment, day of the onset of vasospasm, intracranial pressure, mean arterial pressures, intraarterial treatment of vasospasm, dosages and times of verapamil infusion, presence of a new ischemic area on CT scan, modified Rankin scale score at discharge and at the last clinical follow-up, and discharge status." | 3.76 | Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article. ( Albanese, E; Mericle, RA; Quiroga, M; Russo, A; Ulm, AJ; Willis, RN, 2010) |
| " After receiving a nonselective slow infusion of verapamil, the patient developed an episode of extreme hypertension." | 3.75 | Near-complete resolution of angiographic cerebral vasospasm after extreme elevation of mean arterial pressure: case report. ( Dacey, RG; Derdeyn, CP; Diringer, MN; Moran, CJ; Ray, WZ; Zipfel, GJ, 2009) |
| " Intra-arterial verapamil was started; during this treatment, the patient developed right-sided focal motor seizures." | 3.74 | Intra-arterial verapamil-induced seizures: case report and review of the literature. ( Nwagwu, CI; Westhout, FD, 2007) |
| "We retrospectively reviewed the procedure reports, anesthesia records, clinical charts, and brain images of 29 patients who received intraarterially administered verapamil in 34 procedures for the treatment of vasospasm after subarachnoid hemorrhage from July 1998 to June 2000." | 3.71 | Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. ( Aagaard, BD; Berman, MF; Duong, H; Feng, L; Fitzsimmons, BF; Lin, E; Pile-Spellman, J; Young, WL, 2002) |
| " The most common oral verapamil dosing regimen was controlled release 120 mg once daily." | 3.01 | Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review. ( Bacchi, S; Bagster, M; Collins, L; Goh, R; Gupta, A; Kleinig, O; Kleinig, T; Kovoor, J; Lam, L; Proudman, W; Schultz, D; Zhang, R, 2023) |
| "Patients with cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH) are often treated with intra-arterial (IA) vasodilator infusion." | 1.62 | Use of single versus multiple vasodilator agents in the treatment of cerebral vasospasm: is more better than less? ( Bulsara, K; Chen, PR; Day, AL; Erkmen, K; Kim, DH; Lopez-Rivera, V; Oni-Orisan, AO; Sanzgiri, A; Sheriff, FG; Sheth, S; Vahidy, FS, 2021) |
| "The age is from 8 to 77 years." | 1.56 | Intra-arterial Administration of Verapamil for the Prevention and Treatment of Cerebral Angiospasm. ( Ageev, IS; Belousova, OB; Eliava, SS; Kaftanov, AN; Konovalov, AN; Kurdyumova, NV; Mikeladze, KG; Okishev, DN; Okisheva, EA; Pilipenko, YV; Shekhtman, OD; Tabasaransky, TF; Yakovlev, SB, 2020) |
| "Verapamil was more frequently used for clinical vasospasm in UH patients, at 0." | 1.56 | Discrepancy in Neurologic Outcomes Following Aneurysmal Subarachnoid Hemorrhage as a Function of Socioeconomic Class. ( Amar, A; Bakhsheshian, J; Chartrain, A; Giannotta, SL; Jackanich, A; Mack, W; Mert, M; Ravina, K; Rennert, RC; Russin, JJ; Shahrestani, S; Strickland, BA, 2020) |
| " Quantitative thresholds and analysis based on DSA perfusion may assist with real-time dosage estimation and help predict response to treatment, however future prospective analysis is required for validation." | 1.56 | Computational methods for visualizing and measuring verapamil efficacy for cerebral vasospasm. ( Abumoussa, A; Flores, A; Ho, J; Lee, YZ; Niethammer, M; Sasaki-Adams, D, 2020) |
| "The only pharmacologic prophylaxis for cerebral vasospasm after subarachnoid hemorrhage is oral nimodipine." | 1.46 | Verapamil eluting stents as a possible treatment for vasospasm after subarachnoid hemorrhage. ( Bhambri, P; Mitha, AP; Sarvi, A; Sundararaj, U; Wong, JH, 2017) |
| "Cerebral vasospasm is a devastating complication after subarachnoid hemorrhage." | 1.43 | Initial clinical experience with near-infrared spectroscopy in assessing cerebral tissue oxygen saturation in cerebral vasospasm before and after intra-arterial verapamil injection. ( Flexman, AM; Higashida, RT; Meng, L; Settecase, F; Xiao, J; Yu, Z, 2016) |
| "Verapamil was the most common first-line therapy in the United States, whereas nimodipine was most popular in non-U." | 1.42 | Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia. ( Bulsara, KR; Chen, PR; Coulthard, A; Goddard, AJ; Hollingworth, M; Söderman, M, 2015) |
| "However, posterior reversible encephalopathy syndrome (PRES) is a hyperperfusion syndrome reported as a rare complication of IH that may confound this picture." | 1.42 | Posterior reversible encephalopathy syndrome with thalamic involvement during vasopressor treatment of vertebrobasilar vasospasm after subarachnoid hemorrhage. ( Dhar, R; Madaelil, TP, 2015) |
| "According to angiorraphy cerebral vasospasm in acute rupture of an aneurysm is detected in 50-70% of cases, and the risk of ischemia on it's background is 19-46%." | 1.39 | [Intra-arterial injection of verapamil in treatment of cerebral vasospasm in a patient with acute subarachnoid hemorrhage from an aneurysm: case report]. ( Éliava, ShSh; Iakovlev, SB; Lubnin, AIu; Mikeladze, KG; Shekhtman, OD; Tabasaranskiĭ, TF, 2013) |
| "The dose-response studies revealed that intracarotid administration of nicardipine, compared with verapamil, was more effective in augmenting cerebral blood flow." | 1.34 | Augmentation of cerebral blood flow and reversal of endothelin-1-induced vasospasm: a comparison of intracarotid nicardipine and verapamil. ( Etu, JJ; Joshi, S; Lavine, SD; Meyers, PM; Wang, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (24.44) | 29.6817 |
| 2010's | 25 (55.56) | 24.3611 |
| 2020's | 9 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, L | 1 |
| Lam, L | 1 |
| Kleinig, O | 1 |
| Proudman, W | 1 |
| Zhang, R | 1 |
| Bagster, M | 1 |
| Kovoor, J | 1 |
| Gupta, A | 1 |
| Goh, R | 1 |
| Bacchi, S | 1 |
| Schultz, D | 1 |
| Kleinig, T | 1 |
| Mikeladze, KG | 3 |
| Okishev, DN | 2 |
| Belousova, OB | 2 |
| Konovalov, AN | 2 |
| Pilipenko, YV | 2 |
| Ageev, IS | 1 |
| Kaftanov, AN | 1 |
| Shekhtman, OD | 3 |
| Kurdyumova, NV | 2 |
| Tabasaransky, TF | 2 |
| Okisheva, EA | 1 |
| Eliava, SS | 2 |
| Yakovlev, SB | 1 |
| Varyukhina, MD | 1 |
| Savin, IA | 1 |
| Kheyreddin, AS | 1 |
| Gorozhanin, VA | 1 |
| Spiru, AM | 1 |
| Baranich, AI | 1 |
| Vinogradov, EV | 1 |
| Pressman, E | 1 |
| Penn, D | 1 |
| Patel, NJ | 1 |
| Ospel, JM | 1 |
| Wright, CH | 1 |
| Jung, R | 1 |
| Vidal, LLM | 1 |
| Manjila, S | 1 |
| Singh, G | 1 |
| Heck, DV | 1 |
| Ray, A | 1 |
| Blackham, KA | 1 |
| Liu, X | 1 |
| Vitt, JR | 1 |
| Hetts, SW | 2 |
| Gudelunas, K | 1 |
| Ho, N | 1 |
| Ko, N | 1 |
| Hu, X | 1 |
| Strickland, BA | 1 |
| Mert, M | 1 |
| Ravina, K | 1 |
| Chartrain, A | 1 |
| Rennert, RC | 1 |
| Bakhsheshian, J | 1 |
| Shahrestani, S | 1 |
| Jackanich, A | 1 |
| Amar, A | 1 |
| Mack, W | 1 |
| Russin, JJ | 1 |
| Giannotta, SL | 1 |
| Chen, PR | 2 |
| Bulsara, K | 1 |
| Lopez-Rivera, V | 1 |
| Sheriff, FG | 1 |
| Sanzgiri, A | 1 |
| Sheth, S | 1 |
| Oni-Orisan, AO | 1 |
| Vahidy, FS | 1 |
| Erkmen, K | 1 |
| Kim, DH | 1 |
| Day, AL | 1 |
| Abumoussa, A | 1 |
| Flores, A | 1 |
| Ho, J | 1 |
| Niethammer, M | 1 |
| Sasaki-Adams, D | 1 |
| Lee, YZ | 1 |
| Mao, G | 1 |
| Gigliotti, MJ | 1 |
| Esplin, N | 1 |
| Sexton, K | 1 |
| Al-Mufti, F | 2 |
| Dodson, V | 1 |
| Wajswol, E | 1 |
| El-Ghanem, M | 1 |
| Alchaki, A | 1 |
| Nuoman, R | 1 |
| Thabet, A | 1 |
| Sutherland, A | 1 |
| Roychowdhury, S | 1 |
| Hidalgo, A | 1 |
| Gupta, G | 1 |
| Folzenlogen, Z | 1 |
| Seinfeld, J | 1 |
| Kubes, S | 1 |
| Kumpe, D | 1 |
| Case, D | 1 |
| Roark, C | 1 |
| Akkaya, E | 1 |
| Evran, Ş | 1 |
| Çalış, F | 1 |
| Çevik, S | 1 |
| Hanımoğlu, H | 1 |
| Seyithanoğlu, MH | 1 |
| Katar, S | 1 |
| Karataş, E | 1 |
| Koçyiğit, A | 1 |
| Sağlam, MY | 1 |
| Hatiboğlu, MA | 1 |
| Kaynar, MY | 1 |
| Éliava, ShSh | 1 |
| Lubnin, AIu | 1 |
| Tabasaranskiĭ, TF | 1 |
| Iakovlev, SB | 1 |
| Chia, NH | 1 |
| Kleinig, TJ | 1 |
| Komatsu, T | 1 |
| Kimura, T | 1 |
| Yagishita, A | 1 |
| Takahashi, K | 1 |
| Koide, R | 1 |
| Mortimer, AM | 1 |
| Steinfort, B | 1 |
| Faulder, K | 1 |
| Bradford, C | 1 |
| Finfer, S | 1 |
| Assaad, N | 1 |
| Harrington, T | 1 |
| Hollingworth, M | 1 |
| Goddard, AJ | 1 |
| Coulthard, A | 1 |
| Söderman, M | 1 |
| Bulsara, KR | 1 |
| Chen, SH | 1 |
| Grandhi, R | 1 |
| Deibert, CP | 1 |
| Jovin, TG | 1 |
| Gardner, PA | 1 |
| Ducruet, AF | 1 |
| Madaelil, TP | 1 |
| Dhar, R | 1 |
| Maniskas, ME | 1 |
| Roberts, JM | 1 |
| Aron, I | 1 |
| Fraser, JF | 1 |
| Bix, GJ | 1 |
| Meng, L | 1 |
| Settecase, F | 1 |
| Xiao, J | 1 |
| Yu, Z | 1 |
| Flexman, AM | 2 |
| Higashida, RT | 2 |
| Amuluru, K | 1 |
| Singh, IP | 1 |
| Frohman, LP | 1 |
| Gandhi, CD | 1 |
| Liu, JK | 1 |
| Bhambri, P | 1 |
| Sarvi, A | 1 |
| Wong, JH | 1 |
| Sundararaj, U | 1 |
| Mitha, AP | 1 |
| Kulkarni, M | 1 |
| Chauhan, V | 1 |
| Shetty, S | 1 |
| Perdices, M | 1 |
| Herkes, G | 1 |
| Bouchard, M | 1 |
| Verreault, S | 1 |
| Gariépy, JL | 1 |
| Dupré, N | 1 |
| Shahlaie, K | 1 |
| Boggan, JE | 1 |
| Latchaw, RE | 1 |
| Ji, C | 1 |
| Muizelaar, JP | 1 |
| Lee, DJ | 1 |
| Moftakhar, P | 1 |
| Glenn, TC | 1 |
| Vespa, PM | 1 |
| Martin, NA | 1 |
| Ray, WZ | 1 |
| Moran, CJ | 3 |
| Derdeyn, CP | 3 |
| Diringer, MN | 1 |
| Dacey, RG | 1 |
| Zipfel, GJ | 1 |
| Albanese, E | 1 |
| Russo, A | 1 |
| Quiroga, M | 1 |
| Willis, RN | 1 |
| Mericle, RA | 1 |
| Ulm, AJ | 1 |
| Pierot, L | 1 |
| Aggour, M | 1 |
| Moret, J | 1 |
| Jun, P | 1 |
| Ko, NU | 1 |
| English, JD | 1 |
| Dowd, CF | 1 |
| Halbach, VV | 1 |
| Lawton, MT | 1 |
| Sehy, JV | 1 |
| Holloway, WE | 1 |
| Lin, SP | 1 |
| Cross, DT | 2 |
| Stuart, RM | 1 |
| Helbok, R | 1 |
| Kurtz, P | 1 |
| Schmidt, M | 1 |
| Fernandez, L | 1 |
| Lee, K | 1 |
| Badjatia, N | 1 |
| Mayer, SA | 1 |
| Lavine, S | 1 |
| Meyers, P | 1 |
| Connolly, ES | 1 |
| Claassen, J | 1 |
| French, KF | 1 |
| Hoesch, RE | 1 |
| Allred, J | 1 |
| Wilder, M | 1 |
| Smith, AG | 1 |
| Digre, KB | 1 |
| La Barge, DV | 1 |
| Ryerson, CJ | 1 |
| Talke, PO | 1 |
| Rahme, R | 1 |
| Abruzzo, TA | 1 |
| Zuccarello, M | 1 |
| Ringer, A | 1 |
| Feng, L | 1 |
| Fitzsimmons, BF | 1 |
| Young, WL | 1 |
| Berman, MF | 1 |
| Lin, E | 1 |
| Aagaard, BD | 1 |
| Duong, H | 1 |
| Pile-Spellman, J | 1 |
| Mazumdar, A | 1 |
| Rivet, DJ | 1 |
| Lavine, SD | 1 |
| Wang, M | 1 |
| Etu, JJ | 1 |
| Meyers, PM | 1 |
| Joshi, S | 1 |
| Westhout, FD | 1 |
| Nwagwu, CI | 1 |
| Nishizawa, S | 1 |
| Zhang, JH | 1 |
| Keuskamp, J | 1 |
| Murali, R | 1 |
| Chao, KH | 1 |
| Tanaka, Y | 1 |
| Masuzawa, T | 1 |
| Saito, M | 1 |
| Yamada, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome[NCT02756416] | 10 participants (Anticipated) | Interventional | 2016-07-31 | Not yet recruiting | |||
| The Intra-arterial Vasospasm Trial(iVAST)- A Multi-center Randomized Study[NCT01996436] | Phase 4 | 330 participants (Anticipated) | Interventional | 2016-08-29 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for verapamil and Angiospasm, Intracranial
| Article | Year |
|---|---|
Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review.
Topics: Cerebrovascular Disorders; Humans; Nimodipine; Vasoconstriction; Vasospasm, Intracranial; Verapamil | 2023 |
Posttraumatic vasospasm detected by continuous brain tissue oxygen monitoring: treatment with intraarterial verapamil and balloon angioplasty.
Topics: Adult; Angioplasty, Balloon; Brain Injuries; Female; Humans; Monitoring, Physiologic; Oxygen Consump | 2009 |
Vasospasm after aneurysmal subarachnoid hemorrhage: recent advances in endovascular management.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angioplasty, Balloon; Critical Care; Endovascular Pro | 2010 |
[Basic research and treatment for cerebral vasospasm after subarachnoid hemorrhage: the present and future prospects].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Disease; Angioplasty, Balloon; Calcium Channel | 2008 |
2 trials available for verapamil and Angiospasm, Intracranial
| Article | Year |
|---|---|
[Intracisternal administration of verapamil for the prevention and treatment of vasospasm in patients after microsurgical treatment of cerebral aneurysms in the acute period of hemorrhage].
Topics: Humans; Intracranial Aneurysm; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator Agents; Vasos | 2019 |
Effect of intraarterial verapamil on the diameter of vasospastic intracranial arteries in patients with cerebral vasospasm.
Topics: Cerebral Angiography; Cerebral Arteries; Dose-Response Relationship, Drug; Female; Humans; Infusions | 2006 |
39 other studies available for verapamil and Angiospasm, Intracranial
| Article | Year |
|---|---|
Intra-arterial Administration of Verapamil for the Prevention and Treatment of Cerebral Angiospasm.
Topics: Adolescent; Adult; Aged; Aneurysm, Ruptured; Child; Humans; Middle Aged; Subarachnoid Hemorrhage; Tr | 2020 |
Intracranial Hemorrhage from Meningioma: 2 Novel Risk Factors.
Topics: Basilar Artery; Cerebral Intraventricular Hemorrhage; Citalopram; Coma; Computed Tomography Angiogra | 2020 |
Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.
Topics: Adult; Aged; Cerebrovascular Disorders; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged | 2020 |
Morphological changes of intracranial pressure quantifies vasodilatory effect of verapamil to treat cerebral vasospasm.
Topics: Aged; Cerebrovascular Circulation; Female; Humans; Infusions, Intra-Arterial; Intracranial Pressure; | 2020 |
Discrepancy in Neurologic Outcomes Following Aneurysmal Subarachnoid Hemorrhage as a Function of Socioeconomic Class.
Topics: Female; Health Services Accessibility; Humans; Male; Microsurgery; Middle Aged; Retrospective Studie | 2020 |
Use of single versus multiple vasodilator agents in the treatment of cerebral vasospasm: is more better than less?
Topics: Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nicardipine; Nitroglycerin; Retrospect | 2021 |
Computational methods for visualizing and measuring verapamil efficacy for cerebral vasospasm.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Female; Humans; Male; Middle Aged; Perfusion Im | 2020 |
The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Topics: Aneurysm, Ruptured; Anticonvulsants; Brain Ischemia; Dose-Response Relationship, Drug; Female; Funct | 2021 |
Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome
Topics: Angioplasty; Calcium Channel Blockers; Drug Resistance; Female; Humans; Infusions, Intra-Arterial; M | 2018 |
Use of the PulseRider Device in the Treatment of Ruptured Intracranial Aneurysms: A Case Series.
Topics: Abciximab; Adult; Aged; Aneurysm, Ruptured; Calcium Channel Blockers; Cerebral Angiography; Combined | 2019 |
Effects of Intrathecal Verapamil on Cerebral Vasospasm in Experimental Rat Study.
Topics: Animals; Calcium Channel Blockers; Injections, Spinal; Male; Oxidative Stress; Rats; Rats, Sprague-D | 2019 |
[Intra-arterial injection of verapamil in treatment of cerebral vasospasm in a patient with acute subarachnoid hemorrhage from an aneurysm: case report].
Topics: Acute Disease; Aged; Aneurysm, Ruptured; Female; Humans; Intracranial Aneurysm; Subarachnoid Hemorrh | 2013 |
Verapamil-responsive coital cephalalgia as reversible cerebral vasoconstriction prodrome.
Topics: Cerebral Angiography; Female; Headache; Humans; Imaging, Three-Dimensional; Middle Aged; Vasoconstri | 2014 |
A case of reversible cerebral vasoconstriction syndrome presenting with recurrent neurological deficits: Evaluation using noninvasive arterial spin labeling MRI.
Topics: Calcium Channel Blockers; Cerebrovascular Circulation; Diffusion Magnetic Resonance Imaging; Electro | 2014 |
The detrimental clinical impact of severe angiographic vasospasm may be diminished by maximal medical therapy and intensive endovascular treatment.
Topics: Adult; Endovascular Procedures; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Prospe | 2015 |
Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia.
Topics: Adult; Australasia; Brain Ischemia; Disease Management; Endovascular Procedures; Europe; Female; Hea | 2015 |
Coil herniation following intra-arterial verapamil infusion for the treatment of cerebral vasospasm: Case report and literature review.
Topics: Blood Vessel Prosthesis; Carotid Artery, Internal; Hemiplegia; Hernia; Humans; Infusions, Intra-Arte | 2015 |
Posterior reversible encephalopathy syndrome with thalamic involvement during vasopressor treatment of vertebrobasilar vasospasm after subarachnoid hemorrhage.
Topics: Humans; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Middle Aged; Phenylephrine; Posteri | 2015 |
Stroke neuroprotection revisited: Intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke.
Topics: Acute Disease; Animals; Apoptosis; Behavior, Animal; Brain Ischemia; Calcium Channel Blockers; Cell | 2016 |
Initial clinical experience with near-infrared spectroscopy in assessing cerebral tissue oxygen saturation in cerebral vasospasm before and after intra-arterial verapamil injection.
Topics: Adult; Aged; Brain; Cerebrovascular Circulation; Female; Humans; Injections, Intra-Arterial; Male; M | 2016 |
Reversal of Visual Impairment Associated with Vasospasm After Resection of Sphenoclinoidocavernous Meningioma with Intra-Arterial Verapamil.
Topics: Adrenal Cortex Hormones; Female; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; | 2016 |
Verapamil eluting stents as a possible treatment for vasospasm after subarachnoid hemorrhage.
Topics: Coated Materials, Biocompatible; Drug-Eluting Stents; Humans; Microscopy, Electron, Scanning; Subara | 2017 |
Reversible Cerebral Vasoconstriction Syndrome.
Topics: Adult; Brain Infarction; Circle of Willis; Coronary Vasospasm; Female; Headache Disorders, Primary; | 2016 |
Reversible cerebral vasoconstriction syndrome.
Topics: Adult; Brain; Female; Headache Disorders, Primary; Humans; Neuropsychological Tests; Vasodilator Age | 2018 |
Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.
Topics: Anti-Inflammatory Agents; Brain; Calcium Channel Blockers; Cerebral Angiography; Female; Headache Di | 2009 |
Intra-arterial calcium channel blocker infusion for treatment of severe vasospasm in traumatic brain injury: case report.
Topics: Accidents, Traffic; Adult; Brain Injuries; Calcium Channel Blockers; Cerebral Angiography; Cerebral | 2008 |
Near-complete resolution of angiographic cerebral vasospasm after extreme elevation of mean arterial pressure: case report.
Topics: Calcium Channel Blockers; Cerebral Angiography; Cerebral Arteries; Cerebrovascular Circulation; Fema | 2009 |
Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article.
Topics: Adult; Aged; Calcium Channel Blockers; Catheterization; Catheters, Indwelling; Cerebral Angiography; | 2010 |
Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Topics: Adult; Angioplasty; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Mal | 2010 |
Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration.
Topics: Adult; Calcium Channel Blockers; Cerebral Angiography; Female; Humans; Infusions, Intra-Arterial; Ma | 2010 |
High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism.
Topics: Adult; Blood Pressure; Brain; Cerebrovascular Circulation; Female; Hemodynamics; Humans; Infusions, | 2011 |
Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome.
Topics: Adult; Aged, 80 and over; Cerebral Arteries; Cerebrovascular Disorders; Female; Humans; Radiography; | 2012 |
Hemodynamic stability after intraarterial injection of verapamil for cerebral vasospasm.
Topics: Adult; Anesthesia, General; Blood Pressure; British Columbia; Cerebral Arteries; Female; Heart Rate; | 2012 |
Intra-arterial veramil-induced seizures: drug toxicity or rapid reperfusion?
Topics: Accidents, Traffic; Adult; Anti-Arrhythmia Agents; Cerebral Angiography; Craniocerebral Trauma; Fema | 2012 |
Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience.
Topics: Calcium Channel Blockers; Cerebral Angiography; Female; Humans; Injections, Intra-Arterial; Male; Mi | 2002 |
Augmentation of cerebral blood flow and reversal of endothelin-1-induced vasospasm: a comparison of intracarotid nicardipine and verapamil.
Topics: Animals; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Endothelin-1; Injections, In | 2007 |
Intra-arterial verapamil-induced seizures: case report and review of the literature.
Topics: Adult; Anticonvulsants; Aphasia, Broca; Carotid Artery, Internal; Female; Functional Laterality; Hum | 2007 |
High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Heart Rat | 2008 |
Inhibitory effects of verapamil and nitroglycerin on contraction and cytosolic Ca2+ levels in cerebrovascular smooth muscle during chronic cerebral vasospasm.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Chronic Disease; Cytosol; Disease Models, Anima | 2001 |